Astera Labs (NASDAQ:ALAB – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11, FiscalAI reports. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the company earned $0.44 EPS. The firm’s revenue was up 104.5% on a year-over-year basis. Astera Labs updated its Q3 2026 guidance to 1.160-1.210 EPS.
Here are the key takeaways from Astera Labs’ conference call:
- Record Q2 revenue reached $392.4 million, up 27% sequentially and 104% year over year, with broad-based strength across AI fabric and signal-conditioning products. Non-GAAP operating margin expanded to 39.1% and diluted EPS rose to $0.80.
- Management expects Q3 revenue of $540 million to $560 million, representing approximately 40% sequential growth at the midpoint, driven by the Scorpio X-Series volume ramp, PCIe 6.0 Aries demand, and early Taurus 800G shipments. Scorpio is expected to become the company’s largest product family in Q3.
- Scorpio X-Series is entering high-volume production with the lead customer, while more than 10 customers are engaged across production, pre-production, or qualification programs. Management said the platform could eventually deliver more than $1,000 of content per accelerator, supported by higher-radix switching, software-enabled in-network compute, and HyperCast features.
- Astera highlighted several longer-term growth opportunities, including UALink, CXL memory connectivity, optical interconnects, and custom silicon. Initial optical deployments are targeted for 2027, CPO products for 2028 and beyond, and custom CXL and connectivity design wins are expected to begin shipping in 2027.
- Q3 non-GAAP gross margin is expected to decline to approximately 72% from 73.7% in Q2 as product mix broadens toward switching and module-related revenue. Management expects margins to trend toward a long-term target of roughly 70% despite continued operating leverage.
Astera Labs Stock Performance
Astera Labs stock opened at $361.67 on Wednesday. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48. The firm’s 50-day moving average is $361.12 and its 200-day moving average is $232.51. The company has a market cap of $61.99 billion, a P/E ratio of 244.37, a PEG ratio of 3.72 and a beta of 3.84.
Insider Buying and Selling at Astera Labs
Institutional Trading of Astera Labs
Several hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada grew its stake in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC lifted its stake in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its holdings in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares during the period. First Trust Advisors LP boosted its holdings in shares of Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after acquiring an additional 56,952 shares during the period. Finally, Brown Advisory Inc. grew its position in shares of Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after acquiring an additional 1,977 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on ALAB. JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Bank of America lifted their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Evercore reaffirmed an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Astera Labs in a research note on Wednesday. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $306.25.
Get Our Latest Analysis on ALAB
Astera Labs News Roundup
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Strong Q2 earnings and revenue: Astera Labs reported adjusted earnings of $0.80 per share, exceeding the $0.69 consensus estimate and rising from $0.44 a year earlier. Revenue reached a record $392.4 million, beating expectations of approximately $361 million and increasing 104.5% year over year. Astera Labs Beats Q2 Earnings and Revenue Estimates
- Positive Sentiment: Exceptional Q3 outlook: Management forecast third-quarter EPS of $1.16–$1.21, versus consensus of $0.73, and revenue of $540–$560 million, compared with expectations of roughly $410 million. The outlook represents a significant potential acceleration in growth and is the primary catalyst behind the positive market reaction. Astera Labs Earnings and Guidance
- Positive Sentiment: AI infrastructure product ramp: The company said Q3 growth should be driven by production ramp-up of its Scorpio X-Series 320-lane fabric switch, with strength diversified across AI fabrics and signal-conditioning products. Investor attention is also focused on the potential benefits of Astera Labs’ Amazon partnership. Astera Labs Reports Second Quarter 2026 Financial Results
- Neutral Sentiment: Valuation and volatility remain risks: ALAB trades at a very elevated earnings multiple and has historically high volatility, so expectations are already demanding. Any delay in AI infrastructure deployments or weakness in forward guidance could produce sharp pullbacks.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Palantir Soars 30% After Blockbuster Earnings—Is the Rally Just Getting Started?
- Visa’s BioCatch Deal Could Make Fraud Prevention a Bigger Business
- Caterpillar’s Record Quarter May Have Reset the Stock’s Ceiling
- The Real Reason Amazon Hit a $3 Trillion Valuation
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
